ClinicalTrials.gg
RecruitingNCT05414708Updated Jan 8, 2026

Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms

An interventional study of Art Therapy in PTSD, Military Activity and Post-Traumatic Headache, sponsored by Walter Reed National Military Medical Center. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Walter Reed National Military Medical Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2022; still recruiting 4 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 1,662 studies in Stress Disorders, Post-Traumatic with a site in United States — 340 open to participants now, 405 under way, 18 of them phase 3. Stress Disorders, Post-Traumatic · United States.

Planned enrollment
963rd of 1,489
40 · median 66
Started
2022
with 115 others
No phase
1,010 of 1,662
233 open now
Primary completion
2026-12
later than 104 of 404 live
Registered
1,186th of 1,662
by date

Among the 1,662 studies in Stress Disorders, Post-Traumatic with a site in United States, this one is the 963rd largest by planned enrollment of the 1,489 interventional ones, is one of 116 that started in 2022, is one of 1,010 with no phase, reaches primary completion later than 104 of the 404 other live ones, and was the 1,186th registered.

By phase

1,662 studies; the count open now beside each. This study's row is marked.

No phasethis study1,010 · 233 open
Phase 2168 · 38 open
Observational166 · 24 open
Phase 197 · 18 open
Phase 490 · 10 open
Phase 364 · 8 open
Phase 1/235 · 3 open
Phase 2/331 · 6 open
Other kind1 · 0 open

By the year they started

First in 1991; this study’s year is marked. 116 started in 2022.

Size and results

Median enrollment 66 across the 1,489 interventional studies, 110 across the 165 observational. Of the 1,132 that completed or were terminated, 490 (43%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 1,662 studies in Stress Disorders, Post-Traumatic with a site in United States, or all of them as a file.
02

Study summary

Art therapy is used across the Military Health System for treatment of posttraumatic symptoms, but there is limited research on how art therapy is able to restore emotional expression and regulation in service members. This research hopes to learn about the effects of art therapy on emotional expression and regulation in service members as well as the neurological systems at work. If a participant chooses to be in this study, he or she will attend eleven sessions over a period of six to eight months. The first session will be an interview and self-assessment questionnaires to collect information on a variety of symptoms, experiences, and personality traits, and an MRI scan. During the MRI scan, participants will be asked to perform a task where they will be shown a series of neutral and negative images. The following eight sessions will be one-hour art therapy sessions with a certified art therapist. The tenth session will consist of the same self-assessment questionnaires and another MRI scan. The final session will consist of some of the same questionnaires from the tenth visit, as well as a qualitative interview done virtually three months after the tenth visit.

Read the detailed description

Art Therapy is used across the Military Health System (MHS) as part of interdisciplinary treatment programs with great success, but there is limited research on how this art therapy works. Therefore, the purpose of this research is to learn about the effects of art therapy on emotional expression and regulation in service members as well as the impact of art therapy on brain systems. If a participant chooses to be in this study he or she will attend eleven sessions over a period of six to eight months. The first session and tenth sessions of this research study will include interviews and self-assessment questionnaires to collect information on a variety of symptoms, experiences, and personality traits, and a magnetic resonance imaging (MRI) scan. During the MRI scan, participants will be asked to perform a task where they will be shown a series of neutral and negative images. These sessions will be about 2.5 to 3 hours. The sessions two through nine will include a one-hour art therapy sessions with a certified art therapist. The art therapy sessions are also considered research interventions. The eleventh and final session will consist of some of the same questionnaires from the tenth visit, as well as a qualitative interview done virtually three months after the tenth visit.

There is the risk that participants may experience increased psychological or emotional distress or frustration when discussing traumatic events during either the art research intervention sessions or during the questionnaires or interviews. Participants may experience a reduction in symptoms associated with posttraumatic stress (PTS), mild traumatic brain injury (mTBI), and/or other psychological heath disorders through the art therapy process. However, there is no guarantee that participants will benefit from being in this research. As an alternative to this research, participants can talk to your physician about art therapy or other therapeutic options.

03

Conditions studied

  • PTSD
  • Military Activity
  • Post-Traumatic Headache
  • Posttraumatic Stress Disorder
  • Posttraumatic Stress Disorder, Delayed Onset
  • Sleep Disturbance
  • Nightmare
  • Irritable Mood
  • Anger
  • Combat and Operational Stress Reaction
  • Combat Stress Disorders
  • Military Family
  • Military Operations
  • Emotional Regulation
  • Emotion Processing

Keywords

  • PTSD
  • Military
  • Art Therapy
04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • DEERS Eligible
  • Active Duty or Veteran separated within the past 10 years
  • Significant posttraumatic stress symptoms (score of >/=31 on the PCL-5)

Exclusion criteria

Exclusion Criteria:

  • History of moderate, severe, or penetrating brain injury
  • History of psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation
  • History of multiple sclerosis, Huntington's disease, or Alzheimer's disease
  • History of stroke or myocardial infarction
  • History of brain tumor
  • History of seizures
  • Contradictions for MRI (for example, participants will be excluded for pregnancy, metal implants or suspected shrapnel, aneurysm/intracranial clips, cardiac pacemakers or implanted programmable devices or pumps)
  • Unable to provide
  • History of previous exposure to art therapy
  • Active substance use disorder
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Art Therapy Arm

    8 weeks of individual art therapy

    Behavioral: Art Therapy

Interventions

  • BehavioralArt Therapy

    During the art research intervention session, the art therapist will walk you through the creation of various types of art and may spend time asking you about the artwork, how you are felling, as well as your past experiences.

06

What researchers measure

Primary outcomes

  1. The Primary Outcome Measure is analysis of functional neuroimaging metrics

    The primary outcome measure is the analysis of resting state and task based functional MRI data which include but functional connectivity measures between brain regions at rest and during the task as well as functional activation patterns during the task. MRI and a series of task based fMRI sequences.

    Time frame: Baseline

  2. The Primary Outcome Measure is analysis of functional neuroimaging metrics

    The primary outcome measure is the analysis of resting state and task based functional MRI data which include but functional connectivity measures between brain regions at rest and during the task as well as functional activation patterns during the task. MRI and a series of task based fMRI sequences.

    Time frame: Through study completion, an average of 14 weeks

Secondary outcomes

  1. Toronto Alexithymia Scale (TAS-20)

    A 20-item instrument that measures alexithymia defined as trouble identifying and describing emotions. A 20-item instrument that measures alexithymia defined as trouble identifying and describing emotions. Items are rated using a 5-point Likert scale whereby 1 = strongly disagree and 5 = strongly agree.

    Time frame: Baseline

  2. Toronto Alexithymia Scale (TAS-20)

    A 20-item instrument that measures alexithymia defined as trouble identifying and describing emotions. Items are rated using a 5-point Likert scale whereby 1 = strongly disagree and 5 = strongly agree.

    Time frame: Through study completion, an average of 14 weeks

  3. PTSD Checklist for the Diagnostics and Statistics Manual Five (DSM-V) (PCL-5)

    A 20-item self-report measure of the 20 DSM-5 symptoms of PTSD. Respondents rate how much they were "bothered by that problem in the past month". Items are rated on a scale ranging from 0 ("not at all") to 4 ("extremely")

    Time frame: Baseline

  4. PTSD Checklist for the Diagnostics and Statistics Manual Five (DSM-V) (PCL-5)

    A 20-item self-report measure of the 20 DSM-5 symptoms of PTSD. Respondents rate how much they were "bothered by that problem in the past month". Items are rated on a scale ranging from 0 ("not at all") to 4 ("extremely")

    Time frame: Through study completion, an average of 14 weeks

  5. PTSD Checklist for the Diagnostics and Statistics Manual Five (DSM-V) (PCL-5)

    A 20-item self-report measure of the 20 DSM-5 symptoms of PTSD. Respondents rate how much they were "bothered by that problem in the past month". Items are rated on a scale ranging from 0 ("not at all") to 4 ("extremely")

    Time frame: Study completion, an average of six to eight months

  6. Neurobehavioral Symptoms Inventory (NSI)

    A self-reported questionnaire that measures common post concussive symptoms. The severity of each symptom as experienced in the last two weeks is rated on a scale (0) none to (4) very severe

    Time frame: Baseline

  7. Neurobehavioral Symptoms Inventory (NSI)

    A self-reported questionnaire that measures common post concussive symptoms. The severity of each symptom as experienced in the last two weeks is rated on a scale (0) none to (4) very severe

    Time frame: Through study completion, an average of 14 weeks

  8. Neurobehavioral Symptoms Inventory (NSI)

    A self-reported questionnaire that measures common post concussive symptoms. The severity of each symptom as experienced in the last two weeks is rated on a scale (0) none to (4) very severe

    Time frame: Study completion, an average of six to eight months

  9. General Self Efficacy Scale (GSES)

    A self-report questionnaire that predicts coping with and adapting to stressful life event. The extent to which the participant agrees with each statement is measured on a scale of 1 (not true at all) to 4 (exactly true).

    Time frame: Baseline

  10. General Self Efficacy Scale (GSES)

    A self-report questionnaire that predicts coping with and adapting to stressful life event. The extent to which the participant agrees with each statement is measured on a scale of 1 (not true at all) to 4 (exactly true).

    Time frame: Through study completion, an average of 14 weeks

  11. General Self Efficacy Scale (GSES)

    A self-report questionnaire that predicts coping with and adapting to stressful life event. The extent to which the participant agrees with each statement is measured on a scale of 1 (not true at all) to 4 (exactly true).

    Time frame: Study completion, an average of six to eight months

  12. Generalized Anxiety Disorder-7 (GAD-7)

    A self-rated questionnaire that screens for generalized anxiety disorder. A recommended threshold for further evaluation is a score of 10 or greater

    Time frame: Baseline

  13. Generalized Anxiety Disorder-7 (GAD-7)

    A self-rated questionnaire that screens for generalized anxiety disorder. A recommended threshold for further evaluation is a score of 10 or greater

    Time frame: Through study completion, an average of 14 weeks

  14. Generalized Anxiety Disorder-7 (GAD-7)

    A self-rated questionnaire that screens for generalized anxiety disorder. A recommended threshold for further evaluation is a score of 10 or greater

    Time frame: Study completion, an average of six to eight months

  15. Self-Regulation Questionnaire (SRQ)

    A self-report questionnaire that measures the ability to develop, implement, and flexibly maintain planned behavior. The extent to which the participant agrees with each statement is rated on a scale of 1 (strongly disagree) to 5 (strongly agree).

    Time frame: Baseline

  16. Self-Regulation Questionnaire (SRQ)

    A self-report questionnaire that measures the ability to develop, implement, and flexibly maintain planned behavior. The extent to which the participant agrees with each statement is rated on a scale of 1 (strongly disagree) to 5 (strongly agree).

    Time frame: Through study completion, an average of 14 weeks

  17. Self-Regulation Questionnaire (SRQ)

    A self-report questionnaire that measures the ability to develop, implement, and flexibly maintain planned behavior. The extent to which the participant agrees with each statement is rated on a scale of 1 (strongly disagree) to 5 (strongly agree).

    Time frame: Study completion, an average of six to eight months

  18. Perceived Stress Scale (PSS)

    A self-report questionnaire that measures the level of perceived stress for a participant. How often the participant experiences each event is rated on a scale of 0 (never) to 4 (very often).

    Time frame: Baseline

  19. Perceived Stress Scale (PSS)

    A self-report questionnaire that measures the level of perceived stress for a participant. How often the participant experiences each event is rated on a scale of 0 (never) to 4 (very often).

    Time frame: Through study completion, an average of 14 weeks

  20. Perceived Stress Scale (PSS)

    A self-report questionnaire that measures the level of perceived stress for a participant. How often the participant experiences each event is rated on a scale of 0 (never) to 4 (very often).

    Time frame: Study completion, an average of six to eight months

  21. Revised Helping Alliance Questionnaire (HAQ-II)

    A self-report questionnaire that measures the strength of the client therapist alliance. The extent to which the participant agrees with each statement is rated on a scale of 1 (strongly disagree) to 6 (strongly agree)

    Time frame: Through study completion, an average of 14 weeks

  22. Moral Injury Events Scale (MIES)

    A self-report survey that measures potentially morally injurious events. Each phrase is reacted on a Likert scale of 1 (Strongly Agree) to 6 (strongly disagree).

    Time frame: Baseline

  23. Moral Injury Events Scale (MIES)

    A self-report survey that measures potentially morally injurious events. Each phrase is reacted on a Likert scale of 1 (Strongly Agree) to 6 (strongly disagree).

    Time frame: Through study completion, an average of 14 weeks

07

Study locations

2 of 2 sites recruiting
  • National Intrepid Center of Excellence
    Bethesda, Maryland 20814, United States
    Recruiting
  • ISC at Fort Belvoir
    Fort Belvoir, Virginia 22060, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for Dec 2026, 58 months after the start.

Of 1,064 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 58 months is above that.

Counting every sponsor, half of 1,092 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 15, 2021
First posted
Jun 10, 2022
StartActual
Feb 1, 2022
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2027
Last update
Jan 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05414708
Lead sponsor
Walter Reed National Military Medical Center
Collaborators
University of Pennsylvania, Uniformed Services University of the Health Sciences, Henry M. Jackson Foundation for the Advancement of Military Medicine
Responsible party
Sponsor
First posted
Jun 10, 2022
Start date
Feb 1, 2022
Primary completion
Dec 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jan 8, 2026

Study contacts

Chandler Rhodes, Ph.D.
Contact
chandler.s.rhodes.civ@health.mil
301-400-3638
Julie Sakla, M.A.
Contact
julie.sakla.ctr@health.mil
Chandler Rhodes, PhD
principal investigator · WRNMMC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion